Characterization of the mechanism of action and efficacy of MEN1611 (PA799), a novel PI3K inhibitor, in breast cancer preclinical models Meeting Abstract


Authors: Fiascarelli, A.; Merlino, G.; Capano, S.; Paoli, A.; Bressan, A.; Bigioni, M.; Scaltriti, M.; Arribas, J.; Morales, C. B.; Pellacani, A.; Salerno, M.; Binaschi, M.
Abstract Title: Characterization of the mechanism of action and efficacy of MEN1611 (PA799), a novel PI3K inhibitor, in breast cancer preclinical models
Meeting Title: 44th ESMO Congress (ESMO 2019)
Journal Title: Annals of Oncology
Volume: 30
Issue: Suppl. 5
Meeting Dates: 2019 Sep 27-Oct 1
Meeting Location: Barcelona, Spain
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2019-10-01
Start Page: mdz268.065
Language: English
ACCESSION: WOS:000491295505204
PROVIDER: wos
DOI: 10.1093/annonc/mdz268.065
Notes: Meeting Abstract: 1938P -- Appears on pages v781-v782 of the abstract book -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Maurizio Scaltriti
    169 Scaltriti